标题
Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume 29, Issue 11, Pages 925-934
出版商
Springer Nature
发表日期
2012-10-27
DOI
10.1007/s12325-012-0060-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer
- (2012) Yan Feng et al. Journal of Thoracic Oncology
- The Role of External Beam Radiation and Targeted Therapy in Thyroid Cancer
- (2012) James Brierley et al. SEMINARS IN RADIATION ONCOLOGY
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
- (2011) Caterina Mian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas
- (2011) Margarida M. Moura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant external beam radiation for medullary thyroid carcinoma
- (2010) Steve R. Martinez et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
- (2010) Clarissa Capp et al. THYROID
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- RETgenotypes in sporadic medullary thyroid cancer: studies in a large Italian series
- (2008) Laura Fugazzola et al. CLINICAL ENDOCRINOLOGY
- Serum vascular endothelial growth factor levels in patients with medullary thyroid carcinoma
- (2008) Maria João Bugalho et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
- (2007) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New therapeutic approaches to treat medullary thyroid carcinoma
- (2007) Martin Schlumberger et al. Nature clinical practice. Endocrinology & metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started